SCHEMBL5824601

SCHEMBL5824601

COc1cc2nccc(Oc3cc(C)c(NC(=O)OCCN4CCOCC4)cc3C)c2cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.56
EGFR P00533 3/20 0.56
FLT3 P36888 5/20 0.56
MET P08581 11/20 0.54
AXL P30530 3/20 0.54
FGFR2 P21802 2/20 0.54
PLK4 O00444 1/20 0.54
STK25 O00506 1/20 0.54
CIT O14578 1/20 0.54
AURKA O14965 1/20 0.54
CHUK O15111 1/20 0.54
MUSK O15146 1/20 0.54
EPHB6 O15197 1/20 0.54
MAPK13 O15264 1/20 0.54
MAP3K13 O43283 1/20 0.54
DAPK3 O43293 1/20 0.54
MAP3K7 O43318 1/20 0.54
RIPK2 O43353 1/20 0.54
JAK2 O60674 1/20 0.54
ROCK2 O75116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5824454 0.95 FLT3 (0.60) KDREGFRFLT3METAXL
SCHEMBL5825911 0.92 KDR (0.55) KDRMETKITPDGFRA
SCHEMBL5824741 0.88 FLT3 (0.58) KDREGFRFLT3METAXL
SCHEMBL5824505 0.88 FLT3 (0.54) KDREGFRFLT3METAXL
SCHEMBL5208075 0.87 FLT3 (0.56) KDREGFRFLT3METAXL
SCHEMBL5205891 0.87 FLT3 (0.59) KDREGFRFLT3METAXL
SCHEMBL5824999 0.87 EHMT2 (0.56) KDRFLT3METFGFR2PDGFRB
SCHEMBL5824461 0.87 MET (0.56) KDREGFRFLT3METAXL
SCHEMBL5825147 0.86 FLT3 (0.49) KDREGFRFLT3METAXL
SCHEMBL5825397 0.85 KDR (0.58) KDREGFRKITSRCPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KDR 4/4885EGFR 24/4885FLT3 68/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KDR 5/4885EGFR 20/4885FLT3 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.